Vatalanib: all 32 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Vatalanib in Treating Patients With Recurrent or Progressive MeningiomaCompletedNCT00348790Phase 2Results posted
- PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple MyelomaTerminatedNCT00240162Phase 2Results posted
- Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic CancerCompletedNCT00185588Phase 1/2Results posted
- Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic SyndromesCompletedNCT00072475Phase 2Results posted
- Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid TumorsCompletedNCT00731861Phase 1
- Everolimus and Vatalanib in Treating Patients With Advanced Solid TumorsCompletedNCT00655655Phase 1
- PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced MalignanciesCompletedNCT00611793Phase 1
- Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine TumorsCompletedNCT00590343Phase 2
- Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by SurgeryCompletedNCT00563823Phase 2
- PTK787 in Refractory or Relapsed Diffuse Large Cell LymphomaTerminatedNCT00511043Phase 2
- Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid TumorsCompletedNCT00390000Phase 1
- Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant GliomaCompletedNCT00387933Phase 1
- PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic DrugsCompletedNCT00385853Phase 1
- Trial of PTK787/ZK 222584 Plus PaclitaxelTerminatedNCT00358163Phase 1
- Vatalanib and Everolimus in Treating Patients With Advanced Solid TumorsCompletedNCT00303732Phase 1
- Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate CancerTerminatedNCT00293371Phase 1/2
- Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer PatientsCompletedNCT00268918Phase 1
- PTK and Letrozole in Post-menopausal Women With Advanced Breast CancerTerminatedNCT00263198Phase 2
- Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsWithdrawnNCT00227773Phase 2
- PTK787 in Patients With Advanced Metastatic Pancreatic AdenocarcinomaCompletedNCT00226005Phase 2
- PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast CancerTerminatedNCT00216047Phase 1/2
- Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced CancerCompletedNCT00171587Phase 1/2
- Protein Tyrosine Kinases (PTK) in Multiple MyelomaCompletedNCT00165347Phase 2
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.CompletedNCT00160043Phase 2
- Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT00138632Phase 1/2
- Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate CancerCompletedNCT00134355Phase 2
- Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00128700Phase 1/2
- PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to ImatinibCompletedNCT00117299Phase 2
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.CompletedNCT00056459Phase 3
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00056446Phase 3
- PTK787/ZK 222584 in Treating Patients With Unresectable Malignant MesotheliomaCompletedNCT00053885Phase 2
- Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584CompletedNCT00052013Phase 2